THRM Venowawe issues - Where is the payment?
https://stockhouse.com/news/press-releases/2021/06/28/therma-bright-secures-us-distributor-dme-authority-for-its-patented-venowave Therma Bright Secures US Distributor 'DME Authority' for Its Patented Venowave Lightweight Deep Vein Thrombosis (DVT) Device, Just as US Healthcare Providers Deal with Device Shortages
V.THRM | June 28, 2021 Toronto, Ontario--(Newsfile Corp. - June 28, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of its smart-enabled AcuVid™ COVID-19 Rapid Antigen Saliva Test and other progressive diagnostic and medical device technologies, is pleased to announce that it has secured an exclusive US distributor, a Nashville, Tennessee based organization, DME Authority for Therma's patented FDA approved Venowave,a lightweight Deep Vein Thrombosis (DVT) prophylaxisdevice. The multi-year agreement provides
Therma Bright with a $10 Million annual minimum purchase commitment, with the
initial signing order of 5,000 units coming at a time when competitive mobile DVT prevention devices of the same product category are scarce, on back-order, or indefinitely unavailable in the US due to chip manufacturer shortages similarly affecting many other major industries.
ORIGINAL: Therma Bright Ships Initial Venowave Order to US Distributor
2022-04-28 15:12 ET - News Release
Toronto, Ontario--(Newsfile Corp. - April 28, 2022) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), a progressive medical device technology company and developer of the AcuVid™ Covid-19 Rapid Antigen Saliva Test, is pleased to announce that the initial order of its updated Venowave product has been shipped to its US distributor, DME Authority, LLC, from Therma's Chinese contract manufacturer.
As previously announced on December 16, 2021 the initial order consists of 2,500 units, each unit consists of 2 Venowave devices, of which 500 units have been shipped by air, with the balance being shipped by sea. https://www.stockwatch.com/News/Item/Z-C!THRM-3307267/C/THRM?&fmt=orig ORIGINAL: Therma Bright
Receives Payment for Initial Venowave Sales
2022-09-20 15:43 ET - News Release
Toronto, Ontario--(Newsfile Corp. - September 20, 2022) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer of its smart-enabled AcuVid(TM) COVID-19 Rapid Antigen Saliva Test and other progressive diagnostic and medical device technologies, is pleased to announce that the initial order of its updated Venowave product has been sold to customers in the US by our exclusive distributor, DME Authority. Therma Bright is pleased to
announce it has received payment towards this initial order. THERMA BRIGHT INC.
CONDENSED
INTERIM FINANCIAL STATEMENTS THREE MONTHS ENDED
OCTOBER 31, 2022 Therma Bright Inc.
Condensed Interim Statements of Loss and Comprehensive Loss
(Expressed in Canadian Dollars) Unaudited
Three Months Ended October 31, 2022 Three Months Ended , October31,2021
Revenue
$ 5,948 $ 253
You have to provide an explanation for this, as this could be considered like a stock manipulation